151 related articles for article (PubMed ID: 8636005)
1. Expression of CD44 variant exons 8-10 in gastric cancer.
Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
[TBL] [Abstract][Full Text] [Related]
2. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
Yamaguchi A; Urano T; Goi T; Saito M; Takeuchi K; Hirose K; Nakagawara G; Shiku H; Furukawa K
J Clin Oncol; 1996 Apr; 14(4):1122-7. PubMed ID: 8648366
[TBL] [Abstract][Full Text] [Related]
3. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
[TBL] [Abstract][Full Text] [Related]
5. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
6. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
7. CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer.
Choi ES; Kim H; Kim HP; Choi Y; Goh SH
Sci Rep; 2017 Jul; 7(1):4930. PubMed ID: 28694503
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression.
Yasui W; Kudo Y; Naka K; Fujimoto J; Ue T; Yokozaki H; Tahara E
Int J Oncol; 1998 Jun; 12(6):1253-8. PubMed ID: 9592182
[TBL] [Abstract][Full Text] [Related]
9. De-novo expression of CD44 and survival in gastric cancer.
Mayer B; Jauch KW; Günthert U; Figdor CG; Schildberg FW; Funke I; Johnson JP
Lancet; 1993 Oct; 342(8878):1019-22. PubMed ID: 7692200
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 variants in gastric carcinoma with or without Epstein-Barr virus.
Chong JM; Fukayama M; Hayashi Y; Funata N; Takizawa T; Koike M; Muraoka M; Kikuchi-Yanoshita R; Miyaki M; Mizuno S
Int J Cancer; 1997 Aug; 74(4):450-4. PubMed ID: 9291438
[TBL] [Abstract][Full Text] [Related]
11. CD44 with variant exons 8-10 in colorectal tumors.
Goi T; Yamaguchi A; Takeuchi K; Nakagawa G; Yamashiro S; Furukawa K; Urano T; Shiku H
Int J Oncol; 1996 Apr; 8(4):657-62. PubMed ID: 21544409
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of the CD44 variant exons in oral squamous cell carcinoma and its relationship to metastasis.
Ue T; Yokozaki H; Kagai K; Higashikawa K; Yasui W; Sugiyama M; Tahara E; Ishikawa T
J Oral Pathol Med; 1998 May; 27(5):197-201. PubMed ID: 9682981
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
14. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
[TBL] [Abstract][Full Text] [Related]
15. Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Cai SR; Ma JP
World J Gastroenterol; 2004 Mar; 10(6):776-82. PubMed ID: 15040016
[TBL] [Abstract][Full Text] [Related]
16. Molecular studies into the role of CD44 variants in metastasis in gastric cancer.
Hsieh HF; Yu JC; Ho LI; Chiu SC; Harn HJ
Mol Pathol; 1999 Feb; 52(1):25-8. PubMed ID: 10439835
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
Koyama S; Maruyama T; Adachi S
J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.
Yamaguchi A; Goi T; Yu J; Hirono Y; Ishida M; Iida A; Kimura T; Takeuchi K; Katayama K; Hirose K
J Surg Oncol; 2002 Apr; 79(4):230-5. PubMed ID: 11920780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
